CD274 and non-small cell lung carcinoma: SKYSCRAPER-01 is aim to evaluate how well tiragolumab plus atezolizumab compared with Placebo plus atezolizumab in previously untreated locally advanced unresectable or metastatic PD-L1-selected NSCLC.